SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

Bellerophon to Present at the H.C. Wainwright 21st Annual Global Investment Conference
[September 04, 2019]

Bellerophon to Present at the H.C. Wainwright 21st Annual Global Investment Conference


WARREN, N.J., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, announced today that Fabian Tenenbaum, Chief Executive Officer, will present a corporate overview at the H.C. Wainwright 21st Annual Global Investment Conference, being held September 8-10, 2019, in New York City.

Bellerophon Presentation Details
Date: Tuesday, September 10, 2019
Time: 2:10 – 2:35 PM ET
Webcast: http://wsw.com/webcast/hcw5/blph/



About Bellerophon
Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative therapies that address significant unmet medical needs in the treatment of cardiopulmonary diseases. The Company is currently developing multiple product candidates under its INOpulse® program, a proprietary pulsatile nitric oxide delivery system.  For more information, please visit www.bellerophon.com.

Contacts
At Bellerophon: At LifeSci Advisors:
Fabian Tenenbaum, Chief Executive Officer Brian Ritchie
(908) 574-4767 (212) 915-2578
  britchie@lifesciadvisors.com

Primary Logo



[ Back To TMCnet.com's Homepage ]









Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2019 Technology Marketing Corporation. All rights reserved | Privacy Policy